Perspective Therapeutics Inc. (CATX)

Perspective Therapeutics Inc. (CATX) is a Medical Devices company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $259M; returns 1 day -28.8%, 1 week -25.8%, 1 year -44.1%.

Perspective Therapeutics Inc. (CATX) is a clinical-stage radiopharmaceutical development company focused on pioneering advanced cancer treatments. The company utilizes a proprietary theranostic platform that combines alpha-emitting isotope Lead-212 (212Pb) based therapeutics with complementary imaging diagnostics (using isotopes like Pb-203, Ga-68, or Cu-64).

Groups CATX belongs to

• Clinical Stage Biotech
• Biotechnology
• Oncology
• Healthcare
• Cancer Therapeutics
• Life Sciences
• Precision Medicine
• Biopharmaceutical
• Health Diagnostics and Imaging
• Personalized Medicine

CATX financial model: income statement, cash flow and balance sheet